These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25196375)

  • 21. Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial.
    Retnakaran R; Kramer CK; Choi H; Swaminathan B; Zinman B
    Diabetes Care; 2014 Dec; 37(12):3270-8. PubMed ID: 25249651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy.
    Tian J; Wang J; Li Y; Villarreal D; Carhart R; Dong Y; Wen Y; Liu K
    Am J Hypertens; 2012 Dec; 25(12):1242-8. PubMed ID: 22895449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intriguing effects of time to glycemic goal in newly diagnosed type 2 diabetes after short-term intensive insulin therapy.
    Cheng L; Xu M; Lin X; Tang J; Qi Y; Wan Y; Pan X; Chen X; Ren M; Yan L
    Endocr J; 2016 Aug; 63(8):739-46. PubMed ID: 27334121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The undoing and redoing of the diabetic β-cell.
    Wang W; Liu C; Jimenez-Gonzalez M; Song WJ; Hussain MA
    J Diabetes Complications; 2017 May; 31(5):912-917. PubMed ID: 28242267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes.
    Schofield CJ; Sutherland C
    Diabet Med; 2012 Aug; 29(8):972-9. PubMed ID: 22443306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Diabetic Activities of Gastrodia elata Blume Water Extracts Are Mediated Mainly by Potentiating Glucose-Stimulated Insulin Secretion and Increasing β-Cell Mass in Non-Obese Type 2 Diabetic Animals.
    Yang HJ; Kim MJ; Kwon DY; Kim DS; Lee YH; Kim JE; Park S
    Nutrients; 2016 Mar; 8(3):161. PubMed ID: 26978400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choice of early treatment regimen and impact on β-cell preservation in type 2 diabetes.
    Mudaliar S
    Int J Clin Pract; 2013 Sep; 67(9):876-87. PubMed ID: 23952467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early use of insulin for beta cell preservation.
    Kumar A
    J Assoc Physicians India; 2007 Jul; 55 Suppl():26-8. PubMed ID: 17927008
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolic effects of SGLT-2 inhibitors beyond increased glucosuria: A review of the clinical evidence.
    Scheen AJ; Paquot N
    Diabetes Metab; 2014 Dec; 40(6 Suppl 1):S4-S11. PubMed ID: 25554070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin therapy: as early as possible].
    Müssig K
    Dtsch Med Wochenschr; 2016 Apr; 141(8):578-9. PubMed ID: 27078249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes: Part 1.
    Hao S; Umpierrez GE; Daley T; Vellanki P
    Endocrinol Metab Clin North Am; 2023 Mar; 52(1):27-38. PubMed ID: 36754495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved glycemic control enhances the incretin effect in patients with type 2 diabetes.
    An Z; Prigeon RL; D'Alessio DA
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4702-8. PubMed ID: 24092826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Evolutionary Perspective on Basal Insulin in Diabetes Treatment: Basal Insulin in Primary Care.
    Miller EM
    J Fam Pract; 2016 Oct; 65(10 Suppl):S8-S13. PubMed ID: 27846337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-Cell Function and Its Underlying Mechanism 2015.
    Li Y; Wang C; Omar B; Chen L
    J Diabetes Res; 2016; 2016():7638120. PubMed ID: 26783538
    [No Abstract]   [Full Text] [Related]  

  • 37. Improvement of β-cell function ameliorated glycemic variability in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion or in combination with sitagliptin treatment: a randomized control trial.
    Yuan G; Hu H; Wang S; Yang Q; Yu S; Sun W; Qian W; Mao C; Zhou L; Chen D; Wang Z; Gong Q; Wang D
    Endocr J; 2015; 62(9):817-34. PubMed ID: 26194272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-Cell signalling and insulin secretagogues: A path for improved diabetes therapy.
    Seino S; Sugawara K; Yokoi N; Takahashi H
    Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():22-29. PubMed ID: 28880474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of beta-cell management in type 2 diabetes.
    Standl E
    Int J Clin Pract Suppl; 2007 Jun; (153):10-9. PubMed ID: 17594389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenacious D. why beta cells are no match for the relentless persistence of type 2 diabetes.
    Curry A
    Diabetes Forecast; 2015; 68(5):38-41. PubMed ID: 26491753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.